{"id":"https://openalex.org/W2605075815","doi":null,"title":"Hypermutations in gliomas: a potential immunotherapy target.","display_name":"Hypermutations in gliomas: a potential immunotherapy target.","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-01","ids":{"openalex":"https://openalex.org/W2605075815","mag":"2605075815","pmid":"https://pubmed.ncbi.nlm.nih.gov/28371614"},"language":"en","primary_location":{"id":"pmid:28371614","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28371614","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Discovery medicine","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2605075815"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047711662","display_name":"Gaetano Finocchiaro","orcid":"https://orcid.org/0000-0003-3583-4040","observed_orcids":["https://orcid.org/0000-0003-3583-4040"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gaetano Finocchiaro","raw_affiliation_strings":["Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047654491","display_name":"Tiziana Langella","orcid":"https://orcid.org/0000-0003-2302-1309","observed_orcids":["https://orcid.org/0000-0003-2302-1309"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tiziana Langella","raw_affiliation_strings":["Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042838792","display_name":"Cristina Corbetta","orcid":"https://orcid.org/0000-0003-3018-8780","observed_orcids":["https://orcid.org/0000-0003-3018-8780"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cristina Corbetta","raw_affiliation_strings":["Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036842630","display_name":"Serena Pellegatta","orcid":"https://orcid.org/0000-0001-7804-9486","observed_orcids":["https://orcid.org/0000-0001-7804-9486"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Serena Pellegatta","raw_affiliation_strings":["Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, 20133 Milano, Italy","institution_ids":["https://openalex.org/I4210164485"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210164485"],"apc_list":null,"apc_paid":null,"fwci":1.0472,"has_fulltext":false,"cited_by_count":17,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.77395798,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"23","issue":"125","first_page":"113","last_page":"120"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1615000069141388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.8360000252723694},{"id":"https://openalex.org/keywords/hypermutation","display_name":"hypermutation","score":0.6679999828338623},{"id":"https://openalex.org/keywords/mutational-load","display_name":"mutational load","score":0.7749999761581421},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/mismatch-repair-deficiency","display_name":"mismatch repair deficiency","score":0.7099999785423279},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.7300000190734863},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.8230000138282776},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8679999709129333},{"id":"https://openalex.org/keywords/dendritic-cell-immunotherapy","display_name":"dendritic cell immunotherapy","score":0.8920000195503235},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.5889999866485596},{"id":"https://openalex.org/keywords/lynch-syndrome","display_name":"Lynch syndrome","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.7669272422790527},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7576024532318115},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7298254370689392},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.6116622090339661},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.553874135017395},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5419645309448242},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5095949172973633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5078850388526917},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41164571046829224},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3842790126800537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3321174383163452},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25493770837783813},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.20272144675254822},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077204","descriptor_name":"Temozolomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:28371614","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28371614","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Discovery medicine","raw_type":"Journal Article"},{"id":"pmh:oai:boa.unimib.it:10281/161051","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10281/161051","pdf_url":null,"source":{"id":"https://openalex.org/S4306401259","display_name":"BOA (University of Milano-Bicocca)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2605075815","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28371614","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2619169658","https://openalex.org/W2787813201"],"related_works":["https://openalex.org/W4399981416","https://openalex.org/W4248195751","https://openalex.org/W2988734677","https://openalex.org/W3017270631","https://openalex.org/W2971850950","https://openalex.org/W3082126600","https://openalex.org/W4281617619","https://openalex.org/W2925771367","https://openalex.org/W2600281432","https://openalex.org/W2903914616"],"abstract_inverted_index":{"Checkpoint":[0],"inhibitors,":[1],"like":[2,57],"ipilimumab,":[3],"nivolumab,":[4],"and":[5,21,23,36,108,151],"pembrolizumab,":[6],"have":[7],"provided":[8],"a":[9,84,88],"breakthrough":[10],"in":[11,16,46,50,76,136,162],"cancer":[12],"immunotherapy,":[13,185],"such":[14],"as":[15,75],"the":[17,30,37,70,77,81,95,99,111,139,163,168,188],"treatment":[18],"of":[19,32,69,83,90,129,138,165,167],"melanoma":[20],"colorectal":[22],"lung":[24],"cancer.":[25],"The":[26],"close":[27],"relationship":[28],"between":[29],"number":[31,89],"mutations":[33,66,125],"(mutational":[34],"load)":[35],"response":[38],"to":[39,94],"checkpoint":[40,180],"immunotherapy":[41,178],"has":[42],"been":[43],"convincingly":[44],"demonstrated":[45],"these":[47,195],"cancers.":[48],"Hypermutations":[49],"tumors":[51,140],"are":[52,119,132],"caused":[53],"by":[54,64,177,194],"environmental":[55],"factors,":[56],"UV":[58],"radiations":[59],"or":[60,63,126,182],"cigarette":[61],"smoking,":[62],"germinal":[65,116],"affecting":[67],"genes":[68,131],"Mismatch":[71],"Repair":[72],"(MMR)":[73],"machinery,":[74],"Lynch":[78],"syndrome.":[79],"In":[80,106],"context":[82],"high":[85],"mutational":[86],"load,":[87],"neoantigens":[91],"become":[92],"visible":[93],"immune":[96],"system,":[97],"creating":[98],"basis":[100],"for":[101,191],"effective":[102],"T":[103],"cell":[104,184],"responses.":[105],"low-":[107],"high-grade":[109],"gliomas,":[110],"most":[112],"frequent":[113],"brain":[114],"tumors,":[115],"MMR":[117,130],"defects":[118],"rare;":[120],"however,":[121],"hypermutations":[122],"associated":[123],"with":[124,146,179],"decreased":[127],"expression":[128],"rather":[133],"frequent,":[134],"occurring":[135],"20-60%":[137],"at":[141],"recurrence":[142],"after":[143],"alkylating":[144],"chemotherapy":[145],"temozolomide.":[147],"Ongoing":[148],"clinical":[149],"trials":[150],"genomic":[152],"investigations":[153],"will":[154,173],"clarify":[155],"if":[156],"temozolomide-induced":[157],"hypermutations,":[158],"which":[159],"usually":[160],"occur":[161],"presence":[164],"methylation":[166],"methylguanine":[169],"methyltransferase":[170],"gene":[171],"(MGMT),":[172],"be":[174],"effectively":[175],"targeted":[176],"inhibitors":[181],"dendritic":[183],"thus":[186],"improving":[187],"survival":[189],"expectations":[190],"patients":[192],"affected":[193],"tumors.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2605075815","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2017-04-14T00:00:00"}
